Changzhi People's Hospital
10
3
4
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
10%
1 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Laparoscopic Staging for Stage III Gastric Cancer
Role: collaborator
HPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter Study
Role: collaborator
A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC
Role: collaborator
The Safety and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Metastatic Adenocarcinoma
Role: collaborator
ERAS in Totally Laparoscopic Total Gastrectomy for Gastric Cancer
Role: collaborator
Laparoscopic Versus Open Lower Mediastinal Lymphadenectomy for Esophagogastric Junction Cancer
Role: collaborator
A Phase III Study Comparing Total and Partial Omentectomy for Patients With Advanced Gastric Cancer
Role: collaborator
A Multicenter Prospective Clinical Study of Endoscopic Foam Sclerotherapy for Internal Hemorrhoids
Role: collaborator
Stroke Imaging Package Study of Intracranial Atherosclerosis ( SIPS-ICAS )
Role: collaborator
9 Minutes for Colonoscopy Withdrawal
Role: collaborator
All 10 trials loaded